CN102283832B - 一种预防或治疗高血压肥胖患者的药物组合物及用途 - Google Patents
一种预防或治疗高血压肥胖患者的药物组合物及用途 Download PDFInfo
- Publication number
- CN102283832B CN102283832B CN 201110266291 CN201110266291A CN102283832B CN 102283832 B CN102283832 B CN 102283832B CN 201110266291 CN201110266291 CN 201110266291 CN 201110266291 A CN201110266291 A CN 201110266291A CN 102283832 B CN102283832 B CN 102283832B
- Authority
- CN
- China
- Prior art keywords
- orlistat
- group
- valsartan
- prevention
- telmisartan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110266291 CN102283832B (zh) | 2011-09-09 | 2011-09-09 | 一种预防或治疗高血压肥胖患者的药物组合物及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110266291 CN102283832B (zh) | 2011-09-09 | 2011-09-09 | 一种预防或治疗高血压肥胖患者的药物组合物及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102283832A CN102283832A (zh) | 2011-12-21 |
CN102283832B true CN102283832B (zh) | 2013-04-10 |
Family
ID=45330771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110266291 Active CN102283832B (zh) | 2011-09-09 | 2011-09-09 | 一种预防或治疗高血压肥胖患者的药物组合物及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102283832B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105233288A (zh) * | 2015-09-28 | 2016-01-13 | 青岛云天生物技术有限公司 | 一种治疗或预防肥胖型高血压的药物组合物及其用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1908469A1 (en) * | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
CN101756993B (zh) * | 2008-11-10 | 2011-08-17 | 鲁南制药集团股份有限公司 | 用于减肥或治疗代谢综合征的药物组合物 |
-
2011
- 2011-09-09 CN CN 201110266291 patent/CN102283832B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102283832A (zh) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109674958B (zh) | 一种具有降尿酸功效的中药组合物及其制备方法和应用 | |
US9603866B2 (en) | Anti-fatigue composition, formulation and use thereof | |
JPH07507569A (ja) | ヒトの窒素保持の促進方法 | |
WO2008122190A1 (fr) | Composition comprenant de la l-carnitine ou ses dérivés et son utilisation | |
US10967026B2 (en) | Maca compositions and methods of use | |
CN105343056A (zh) | 一种治疗或预防肥胖型高血压的口服药物组合物及其用途 | |
WO2019220335A1 (en) | Compositions for use in the treatment of obesity | |
KR20140116988A (ko) | 메틸설포닐메탄을 함유하는 류마티스 관절염 및 지질 대사 관련 질환의 예방 및 치료를 위한 약학적 조성물 | |
CN102283834B (zh) | 一种含奥利司他的药物组合物及用途 | |
CN105233288A (zh) | 一种治疗或预防肥胖型高血压的药物组合物及其用途 | |
US20230125425A1 (en) | Traditional chinese medicine extract composition with function of regulating depressive emotion and preparation method and traditional chinese medicine preparation thereof | |
CN111265599A (zh) | 番茄红素和葡萄籽组合物在制备治疗关节炎药物中的应用 | |
CN102283832B (zh) | 一种预防或治疗高血压肥胖患者的药物组合物及用途 | |
CN106822097A (zh) | 一种用于减肥的含奥利司他的药物组合物 | |
WO2016124080A1 (zh) | 20(R)-人参皂苷Rg3在制备预防或/和治疗肥胖症药物中的应用及药物 | |
CN105147678A (zh) | 一种用于治疗肥胖或高血压症的口服药物组合物 | |
US20040157913A1 (en) | Kappa opiate agonists for the treatment of bladder diseases | |
CN107213197A (zh) | 一种中药组合物及其在制备预防或治疗高血压药物中的应用 | |
CN106924270A (zh) | 一种含有奥利司他的具有减肥功能的药物组合物 | |
CN102247572B (zh) | 一种治疗高脂血症的药物 | |
CN105617353A (zh) | 一种黏菌素口服给药组合物 | |
CN110935002A (zh) | 具有降血压功效的组合物及其应用 | |
CN103948591B (zh) | 一种减肥药剂 | |
CN111212637A (zh) | 含苯甲酸酯的组合物治疗甘氨酸脑病的用途 | |
CN110420209B (zh) | 一种治疗糖尿病周围神经痛的药物组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Hou Guangchen Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: HOU GUANGCHEN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG JINYU POULTRY DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: NANJING ZHENGKUAN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20131105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 211200 NANJING, JIANGSU PROVINCE TO: 226300 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131105 Address after: The east town of Tongzhou District city of Nantong province Jiangsu 226300 five Jia Ju Ju Patentee after: Nantong Jinyu Poultry Industry Development Co. Ltd. Address before: Qingfeng Village Yong Yang town of Lishui County of Nanjing City, Jiangsu province 211200 Green Village building 301 room 22 Patentee before: Nanjing Zhengkuan Pharmaceutical Science and Technology Co., Ltd. |